CY1112162T1 - Αντι-αβ αντισωμα - Google Patents
Αντι-αβ αντισωμαInfo
- Publication number
- CY1112162T1 CY1112162T1 CY20111101276T CY111101276T CY1112162T1 CY 1112162 T1 CY1112162 T1 CY 1112162T1 CY 20111101276 T CY20111101276 T CY 20111101276T CY 111101276 T CY111101276 T CY 111101276T CY 1112162 T1 CY1112162 T1 CY 1112162T1
- Authority
- CY
- Cyprus
- Prior art keywords
- abeta
- antibody
- free
- low levels
- abeta peptide
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 3
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Neurosurgery (AREA)
- Immunology (AREA)
- Neurology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US54676404P | 2004-02-23 | 2004-02-23 | |
| EP05723280A EP1720909B1 (en) | 2004-02-23 | 2005-02-17 | Anti-abeta antibody |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1112162T1 true CY1112162T1 (el) | 2015-12-09 |
Family
ID=34910810
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20111101276T CY1112162T1 (el) | 2004-02-23 | 2011-12-21 | Αντι-αβ αντισωμα |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US20070190046A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP1720909B1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP4851348B2 (cg-RX-API-DMAC7.html) |
| KR (2) | KR100889430B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN1922209B (cg-RX-API-DMAC7.html) |
| AT (1) | ATE534667T1 (cg-RX-API-DMAC7.html) |
| AU (1) | AU2005217596B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BRPI0507856A (cg-RX-API-DMAC7.html) |
| CA (1) | CA2556436C (cg-RX-API-DMAC7.html) |
| CY (1) | CY1112162T1 (cg-RX-API-DMAC7.html) |
| DK (1) | DK1720909T3 (cg-RX-API-DMAC7.html) |
| EA (1) | EA009872B1 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2375627T3 (cg-RX-API-DMAC7.html) |
| IL (1) | IL177611A (cg-RX-API-DMAC7.html) |
| NO (1) | NO20064239L (cg-RX-API-DMAC7.html) |
| PL (1) | PL1720909T3 (cg-RX-API-DMAC7.html) |
| PT (1) | PT1720909E (cg-RX-API-DMAC7.html) |
| SI (1) | SI1720909T1 (cg-RX-API-DMAC7.html) |
| UA (1) | UA93181C2 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2005082939A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (32)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE10303974A1 (de) | 2003-01-31 | 2004-08-05 | Abbott Gmbh & Co. Kg | Amyloid-β(1-42)-Oligomere, Verfahren zu deren Herstellung und deren Verwendung |
| PL1976877T5 (pl) | 2005-11-30 | 2017-09-29 | Abbvie Inc | Przeciwciała monoklonalne przeciwko białku amyloidu beta oraz ich zastosowania |
| PT1954718E (pt) | 2005-11-30 | 2014-12-16 | Abbvie Inc | Anticorpos anti-globulómeros aβ, suas porções de ligação ao antigénio, correspondentes hibridomas, ácidos nucleicos, vectores, células hospedeiras, métodos de produção dos ditos anticorpos, composições compreendendo os ditos anticorpos, usos dos ditos anticorpos e métodos para uso dos ditos anticorpos |
| MX358175B (es) | 2005-12-12 | 2018-08-08 | Ac Immune Sa | Anticuerpos monoclonales especificos 1-42 beta con propiedades terapeuticas. |
| US7892544B2 (en) | 2006-07-14 | 2011-02-22 | Ac Immune Sa | Humanized anti-beta-amyloid antibody |
| US8455626B2 (en) | 2006-11-30 | 2013-06-04 | Abbott Laboratories | Aβ conformer selective anti-aβ globulomer monoclonal antibodies |
| HRP20140049T1 (hr) | 2007-01-05 | 2014-02-28 | University Of Zürich | Anti beta-amiloid antitijela i njihova upotreba |
| HUE034512T2 (en) | 2007-01-05 | 2018-02-28 | Univ Zuerich | A method for providing disease-specific binding molecules and targets |
| WO2008084402A2 (en) | 2007-01-11 | 2008-07-17 | Philipps-Universitaet Marburg | Diagnosis and treatment of alzheimer's and other neurodementing diseases |
| US20100311767A1 (en) | 2007-02-27 | 2010-12-09 | Abbott Gmbh & Co. Kg | Method for the treatment of amyloidoses |
| US8048420B2 (en) * | 2007-06-12 | 2011-11-01 | Ac Immune S.A. | Monoclonal antibody |
| US8613923B2 (en) | 2007-06-12 | 2013-12-24 | Ac Immune S.A. | Monoclonal antibody |
| PT2238166E (pt) | 2007-10-05 | 2014-02-11 | Genentech Inc | Utilização do anticorpo anti-amilóide beta em doenças oculares |
| RU2542967C2 (ru) * | 2007-10-05 | 2015-02-27 | Дженентек, Инк. | Применение антитела против амилоида бета при глазных заболеваниях |
| EA201190025A1 (ru) | 2008-11-25 | 2012-12-28 | Байоджен Айдек Ма Инк. | ПРИМЕНЕНИЕ АНТАГОНИСТОВ DR6 И p75 ДЛЯ ПРОМОТИРОВАНИЯ ВЫЖИВАНИЯ КЛЕТОК НЕРВНОЙ СИСТЕМЫ |
| BRPI0923157B1 (pt) | 2008-12-19 | 2021-12-28 | University Of Zürich | Anticorpos anti-alfa-sinucleína e seus fragmentos, seus usos e método de preparação, composição compreendendo-os, bem como kit e métodos para o diagnóstico e monitoramento de uma doença sinucleinopática |
| WO2011060246A2 (en) | 2009-11-12 | 2011-05-19 | Genentech, Inc. | A method of promoting dendritic spine density |
| CN102933601B (zh) | 2010-04-15 | 2016-06-08 | Abbvie公司 | β淀粉样蛋白结合蛋白 |
| MY164579A (en) | 2010-07-30 | 2018-01-15 | Ac Immune Sa | Safe and functional humanized antibodies |
| PL3042917T3 (pl) * | 2010-08-12 | 2018-07-31 | Eli Lilly And Company | Przeciwciała przeciwko peptydowi beta amyloidu N3pGlu i ich zastosowanie |
| MX358739B (es) | 2010-08-14 | 2018-09-03 | Abbvie Inc Star | Proteinas de union a amiloide beta. |
| PL2723379T3 (pl) | 2011-06-23 | 2019-05-31 | Biogen Int Neuroscience Gmbh | Cząsteczki wiążące przeciwko alfa-synukleinie |
| US20150209406A1 (en) | 2012-09-07 | 2015-07-30 | Massachusetts Eye And Ear Infirmary | Methods and compositions for regenerating hair cells and/or supporting cells |
| WO2014039781A1 (en) | 2012-09-07 | 2014-03-13 | Massachusetts Eye & Ear Infirmary | Treating hearing loss |
| JP6751344B2 (ja) | 2013-09-13 | 2020-09-02 | ジェネンテック， インコーポレイテッド | 精製された組み換えポリペプチドを含む方法及び組成物 |
| MA41115A (fr) | 2014-12-02 | 2017-10-10 | Biogen Int Neuroscience Gmbh | Procédé de traitement de la maladie d'alzheimer |
| KR102362222B1 (ko) | 2016-05-16 | 2022-02-11 | 더 제너럴 하스피탈 코포레이션 | 폐 상피 공학에서 인간 기도 줄기 세포 |
| WO2018031334A1 (en) * | 2016-08-11 | 2018-02-15 | Eli Lilly And Company | Aminothiazines and their use as bace1 inhibitors |
| AU2018321335B2 (en) | 2017-08-22 | 2025-08-14 | Biogen Ma Inc. | Pharmaceutical compositions containing anti-beta amyloid antibodies |
| TWI843040B (zh) | 2021-01-11 | 2024-05-21 | 美商美國禮來大藥廠 | 抗N3pGlu類澱粉β抗體及其用途 |
| WO2022251048A1 (en) | 2021-05-24 | 2022-12-01 | Eli Lilly And Company | Anti-amyloid beta antibodies and uses thereof |
| JP2025506411A (ja) | 2022-02-03 | 2025-03-11 | イーライ リリー アンド カンパニー | アルツハイマー病の診断及び治療のための局所タウイメージング |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PT951466E (pt) | 1996-12-23 | 2009-04-09 | Lilly Co Eli | Compostos cicloalquilo, lactama, lactona e relacionados, composições farmacêuticas compreendendo os mesmos, e métodos para a inibição da libertação do péptido β-amilóide e/ou da sua síntese pela utilização de tais compostos |
| US6518011B1 (en) * | 1999-01-13 | 2003-02-11 | Bristol-Myers Squibb Company | Method for screening compounds to identify beta-amyloid production modulators |
| MXPA02008145A (es) * | 2000-02-24 | 2004-04-05 | Univ Washington | Anticuerpos humanizados que secuestran al peptido beta amiloide. |
| AU2001257022B2 (en) * | 2000-04-13 | 2005-02-03 | Mayo Foundation For Medical Education And Research | Abeta 42 lowering agents |
| TWI255272B (en) * | 2000-12-06 | 2006-05-21 | Guriq Basi | Humanized antibodies that recognize beta amyloid peptide |
| ES2437875T3 (es) * | 2001-04-30 | 2014-01-14 | Eli Lilly And Company | Anticuerpos humanizados que reconocen el péptido beta-amiloide |
-
2005
- 2005-02-17 UA UAA200609258A patent/UA93181C2/ru unknown
- 2005-02-17 WO PCT/US2005/005198 patent/WO2005082939A2/en not_active Ceased
- 2005-02-17 PT PT05723280T patent/PT1720909E/pt unknown
- 2005-02-17 DK DK05723280.3T patent/DK1720909T3/da active
- 2005-02-17 JP JP2006554230A patent/JP4851348B2/ja not_active Expired - Fee Related
- 2005-02-17 KR KR1020067016812A patent/KR100889430B1/ko not_active Expired - Fee Related
- 2005-02-17 SI SI200531422T patent/SI1720909T1/sl unknown
- 2005-02-17 US US10/590,411 patent/US20070190046A1/en not_active Abandoned
- 2005-02-17 CA CA2556436A patent/CA2556436C/en not_active Expired - Fee Related
- 2005-02-17 EP EP05723280A patent/EP1720909B1/en not_active Expired - Lifetime
- 2005-02-17 AT AT05723280T patent/ATE534667T1/de active
- 2005-02-17 CN CN2005800056858A patent/CN1922209B/zh not_active Expired - Fee Related
- 2005-02-17 AU AU2005217596A patent/AU2005217596B2/en not_active Ceased
- 2005-02-17 PL PL05723280T patent/PL1720909T3/pl unknown
- 2005-02-17 KR KR1020087031635A patent/KR20090005410A/ko not_active Ceased
- 2005-02-17 ES ES05723280T patent/ES2375627T3/es not_active Expired - Lifetime
- 2005-02-17 EA EA200601545A patent/EA009872B1/ru not_active IP Right Cessation
- 2005-02-17 BR BRPI0507856-3A patent/BRPI0507856A/pt not_active IP Right Cessation
-
2006
- 2006-08-21 IL IL177611A patent/IL177611A/en not_active IP Right Cessation
- 2006-09-19 NO NO20064239A patent/NO20064239L/no not_active Application Discontinuation
-
2011
- 2011-12-21 CY CY20111101276T patent/CY1112162T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2005217596B2 (en) | 2012-01-19 |
| US20070190046A1 (en) | 2007-08-16 |
| CN1922209B (zh) | 2012-09-05 |
| KR20090005410A (ko) | 2009-01-13 |
| JP2008500279A (ja) | 2008-01-10 |
| SI1720909T1 (sl) | 2012-01-31 |
| ATE534667T1 (de) | 2011-12-15 |
| IL177611A (en) | 2013-05-30 |
| DK1720909T3 (da) | 2012-01-30 |
| PL1720909T3 (pl) | 2012-04-30 |
| CA2556436C (en) | 2014-04-01 |
| EA009872B1 (ru) | 2008-04-28 |
| NO20064239L (no) | 2006-11-20 |
| EA200601545A1 (ru) | 2007-02-27 |
| PT1720909E (pt) | 2011-12-23 |
| BRPI0507856A (pt) | 2007-07-10 |
| JP4851348B2 (ja) | 2012-01-11 |
| KR100889430B1 (ko) | 2009-03-23 |
| ES2375627T3 (es) | 2012-03-02 |
| UA93181C2 (ru) | 2011-01-25 |
| IL177611A0 (en) | 2006-12-10 |
| AU2005217596A1 (en) | 2005-09-09 |
| KR20060126785A (ko) | 2006-12-08 |
| CN1922209A (zh) | 2007-02-28 |
| EP1720909A2 (en) | 2006-11-15 |
| EP1720909B1 (en) | 2011-11-23 |
| CA2556436A1 (en) | 2005-09-09 |
| WO2005082939A3 (en) | 2005-10-27 |
| WO2005082939A2 (en) | 2005-09-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1112162T1 (el) | Αντι-αβ αντισωμα | |
| CY1124802T1 (el) | Δεσμευτικοι παραγοντες σκληροστινης | |
| AR116860A2 (es) | Composición que comprende anticuerpo que se fija al dominio ii de her2, y sus variantes ácidas | |
| CY1121208T1 (el) | Σκευασματα αντισωματος ναταλιζουμαμπης | |
| CO5720212A1 (es) | Composicion de anticuerpo her2 | |
| DK3530673T3 (da) | Humaniserede anti-beta7-antagonister og anvendelser deraf | |
| EA201991701A1 (ru) | Состав на основе моноклонального антитела к rsv | |
| EA200800812A1 (ru) | Композиции антитела против cd3 | |
| MY174493A (en) | Binding agents | |
| CL2011000010A1 (es) | Anticuerpo monoclonal anti-peptido beta-amiloide; polinucleotido que lo codifica; hibridoma; metodo de produccion; composicion que lo comprende; uso para tratar enfermedades relacionadas con proteinas amiloides; metodo de diagnostico de las mismas; y kit que lo comprende. | |
| MEP35408A (en) | Tweak binding antibodies | |
| EA200901500A1 (ru) | Антитела-нейтрализаторы гранулоцитарно-макрофагального колониестимулирующего фактора человека | |
| GT201200189A (es) | Antagonistas de pcsk9 | |
| NO20083895L (no) | Anti-IGF-1R human monoklonalantibody formulering | |
| ATE553778T1 (de) | Für humanes hepcidin spezifische antikörper | |
| MX373170B (es) | Variantes de la familia il-1. | |
| EA200700702A1 (ru) | Аналоги локсапина и способы их применения | |
| RU2010100549A (ru) | Способ получения n-(1,3,5-дитиазинан-5-ил)-изоникотинамида и n-(2,4,6-триметил-1,3,5-дитиазинан-5-ил)-изоникотинамида | |
| DK1987357T3 (da) | Polypeptider, som genkendes af anti-Trichinella-antistoffer, og anvendelser deraf | |
| ATE550354T1 (de) | Humane ringspezifische bnp-antikörper | |
| CO6382184A2 (es) | Proteinas fijadoras de receptores de interleukinas-21 | |
| DE602005012097D1 (de) | Adjuvante zusammensetzung und anwendungsverfahren dafür | |
| EA200800601A1 (ru) | Связывающие fas антитела | |
| EA200601743A1 (ru) | Выделенный полипептид реналазы и его применение | |
| ATE417849T1 (de) | Pyrazoloä4,3-düpyrimidine |